BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16437457)

  • 1. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler GH
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler G
    Cochrane Database Syst Rev; 2003; (2):CD003508. PubMed ID: 12804472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
    Grimwade K; Swingler ; G
    Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
    Humphreys EH; Smith NA; Azman H; McLeod D; Rutherford GW
    Cochrane Database Syst Rev; 2010 Jun; (6):CD008563. PubMed ID: 20556793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Stern A; Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
    Mulenga V; Ford D; Walker AS; Mwenya D; Mwansa J; Sinyinza F; Lishimpi K; Nunn A; Gillespie S; Zumla A; Chintu C; Gibb DM;
    AIDS; 2007 Jan; 21(1):77-84. PubMed ID: 17148971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
    Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
    J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.
    Chang LW; Phipps WT; Kennedy GE; Rutherford GW
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004773. PubMed ID: 16034947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Wiysonge CS; Shey MS; Sterne JA; Brocklehurst P
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003648. PubMed ID: 16235332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal disinfection for preventing mother-to-child transmission of HIV infection.
    Wiysonge CS; Shey MS; Shang JD; Sterne JA; Brocklehurst P
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003651. PubMed ID: 16235334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
    Ryan M; Griffin S; Chitah B; Walker AS; Mulenga V; Kalolo D; Hawkins N; Merry C; Barry MG; Chintu C; Sculpher MJ; Gibb DM
    AIDS; 2008 Mar; 22(6):749-57. PubMed ID: 18356605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid for preventing tuberculosis in HIV-infected children.
    Zunza M; Gray DM; Young T; Cotton M; Zar HJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Shey WI; Brocklehurst P; Sterne JA
    Cochrane Database Syst Rev; 2002; (3):CD003648. PubMed ID: 12137702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.